Myalgia
Drug research and approvals for myalgia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 55 studies of myalgia are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 55
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 55 recruiting on ClinicalTrials.gov ↗- Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain SyndromeNCT07572994 · Not applicable · Cairo University · starts Nov 1, 2026
- Shower Gel and Participant-Reported Post-Exercise Soreness in Regular ExercisersNCT07908290 · Not applicable · The Humanix · starts Nov 1, 2026
- Mineral-Infused Clothing for Recovery From Muscle Soreness and Muscle Damage After ExerciseNCT07873866 · Not applicable · StudySetGo · starts Nov 1, 2026
- Marine Lipids Ease Painful TMDNCT07437313 · Not applicable · University of North Carolina, Chapel Hill · starts Sep 25, 2026
- The Effects of Tyrosol and Creatine on Exercise Performance and Cognition in Healthy AdultsNCT07756658 · Not applicable · Applied Science & Performance Institute · starts Sep 4, 2026
- The Effect of Different rTMS Interventions on Acute Experimental Muscular Pain in Individuals Comorbid With InsomniaNCT07827677 · Not applicable · The Hong Kong Polytechnic University · starts Aug 31, 2026
- The Impact of Insomnia on Pain Sensitivity and the Trajectory of Exercise-induced Muscular PainNCT07827664 · Not reported · The Hong Kong Polytechnic University · starts Aug 26, 2026
- The Impact of Acute Pain on Sleep Parameters in the Insomnia Population and Healthy ControlsNCT07826650 · Not reported · The Hong Kong Polytechnic University · starts Aug 26, 2026
- Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue SyndromeNCT07753122 · Not applicable · Fred Friedberg · starts Aug 15, 2026
- Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)NCT07621068 · Not applicable · Assaf-Harofeh Medical Center · starts Jul 19, 2026
Drug Pipeline
30 approved, 4 in phase 3, 11 in phase 2; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Diclofenac, Flurbiprofen, Ibuprofen, Indomethacin, Ketoprofen, Meclofenamic acid, Naproxen, Piroxicam, Tolmetin, Lidocaine, Bendazac, Nimesulide, Phenylbutazone, Feprazone, Bufexamac, Oxyphenbutazone anhydrous, Suxibuzone, Tolazoline, Cyclobenzaprine, Menthol, Capsaicin, Aspirin, Methyl salicylate, Dimethyl sulfoxide, Benzydamine, Dexketoprofen, Aceclofenac, Esflurbiprofen, Loxoprofen, Felbinac
- Suxamethonium
- Phase 3 Muscle-type nicotinic acetylcholine receptor agonist
- Rocuronium
- Phase 3 Muscle-type nicotinic acetylcholine receptor antagonist
- Zucapsaicin
- Phase 3 Vanilloid receptor agonist
- Tolperisone
- Phase 3
- Baricitinib
- Phase 2 Tyrosine-protein kinase JAK1 inhibitor
- Duloxetine
- Phase 2 Serotonin transporter inhibitor
- Selenium
- Phase 2
- Mofebutazone
- Phase 2
- Fentiazac
- Phase 2
- Nifenazone
- Phase 2
- Etofenamate
- Phase 2
- Idrocilamide
- Phase 2
- Niflumic acid
- Phase 2
- Clofezone anhydrous
- Phase 2
- Piketoprofen
- Phase 2
How Its Trials Ended
262 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 37 whose ending is known, 51% met their primary endpoint, 5% missed it and 43% stopped early.
- Completed, result not reported15358%
- Ongoing4015%
- Status unknown3212%
- Met its primary endpoint197%
- Stopped: other or unclear93%
- Stopped: enrollment or feasibility31%
- Stopped: funding31%
- Missed its primary endpoint21%
- Stopped: sponsor or business decision10%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA